Mission and collaborations
The Cancer Agent Target Discovery and Aptamer Development (CATDAD) Core at the Baylor Scott & White Research Institute serves as a regional hub for cancer research, supporting:
- Advanced drug target identification
- Aptamer discovery and development to create cost-effective and targeted cancer therapeutics
- High-impact research collaboration to accelerate drug discovery and translational cancer medicine
Our mission is to drive innovation in cancer drug development, enhance precision medicine, and train the next generation of scientists and physician-scientists.
Our services
We provide comprehensive services to researchers focused on cancer therapeutics and target identification, including:
- Drug binding target identification (on-target and off-target)
- Biophysical interaction analysis for molecular binding studies
- Aptamer development for cancer research applications
Training opportunities
We offer regular workshops on our services and techniques, providing users with valuable training and insights. Additionally, users will have the opportunity to present their research projects that have utilized our services, fostering collaboration and knowledge exchange.
Our workflow
To request services and discuss collaborations, please contact the CATDAD Core Director or Core Manager.
Contact us
Erxi Wu, PhD
Professor and Director
CATDAD Core, BSWH
Email: Erxi.Wu@BSWHealth.org
Phone: 254.724.3785
Cancer Agent Target Discovery and Aptamer Development (CATDAD) Core Lab
West Campus
Baylor Scott & White Health
5701 Airport Road
Temple, TX 76502
Acknowledgment of CPRIT and Baylor Research Institute Funding
This research was supported in part by the Cancer Agent Target Discovery and Aptamer Development (CATDAD) Core, funded by the Cancer Prevention and Research Institute of Texas (CPRIT) Grant #RP240537 and Baylor Scott & White Research Institute.